A Clinical Study of VA-CAG as Induction Therapy in Newly Diagnosed AML Patients
Clinical trial NCT05662956 · COMPLETED
Trial details
- NCT number
- NCT05662956
- Sponsor
- Hematology department of the 920th hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-01
- Primary completion
- 2024-12-30
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.